Northern Blotting Market Segmentation:
Product Segment Analysis
Consumables hold the largest share and dominate the northern blotting market, and are poised to have a market share of 45.7% by 2037. The market is mainly driven by the utilization of RNA analysis. The instruments, such as blotting systems and electrophoresis, significantly contribute to automating and enhancing efficiency. As the market is expanding, the shift towards high-throughput blotting solutions in research boosts the demand further. Moreover, the key players in the market introduce ready-to-use kits to reduce the procedural complexity.
Application Segment Analysis
Drug development leads with a market share of 38.9% in 2037. The market of drug development is mainly fueled by the increase in the research of RNA-based therapeutics and biomarker discovery. In part due to developments in precision medicine, the diagnosis is closely followed, especially in infectious and cancer disorders. Furthermore, the academic research segment is a steady contributor, with institutes and universities adopting automated blotting methods. The adoption is further accelerated by government funding for genomic studies in the segment.
Our in-depth analysis of the global northern blotting market includes the following segments:
|
Segment |
Subsegment |
|
Product |
|
|
Application |
|
|
End user |
|
